Search terms
Results 1 - 10 of 67 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 7

Given the burden of cardiovascular disease in patients with diabetes, the focus should shift towards cardiovascular outcome studies designed to evaluate efficacy (i.e. to determine the efficacy of a ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Faiez Zannad, Wendy Gattis Stough, Raymond J. Lipicky, Juan Tamargo, George L. Bakris, Jeffrey S. Borer, Maria de los Angeles Alonso ...

Date : 01/07/2016 Item size : 285307 bytes

Without a doubt, we have made substantial progress: we can lower blood pressure, if it is too high,1 we can treat hyperlipidaemia as again outlined in the 2016 ESC Guidelines,2 and indeed for the ...

European Heart Journal, Issue @ A Glance, Thomas F. Lüscher

Date : 07/11/2016

Abstract Aims The study concerns the relationship of the corrected QT (QTc) interval to 6.4 years of survival and to measures of cardiac function, such as echocardiographic variables and plasma ...

Europace, ELECTROPHYSIOLOGY, Göran Nilsson, P. Hedberg, T. Jonasson, I. Lönnberg, J. Öhrvik

Date : 01/04/2006

In the present study only 0.52% had short PR interval. Because heart rate and PR interval have an inverse relationship during physiological increase of the heart rate, Holmqvist et al. suggest that ...

Europace, Editorial, Casper N. Bang, Peter M. Okin

Date : 01/06/2015

Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease—results from the large AtheroGene study Introduction Stratification for subsequent coronary ...

European Heart Journal, Karakas, Mahir, Schulte, Christian, Appelbaum, Sebastian, Ojeda, Francisco, Lackner, Karl J., Münzel, Thomas, Schnabel, Renate B., Blankenberg, Stefan, Zeller, Tanja

Date : 14/02/2017 Item size : 125906 bytes

[...]there has been a call for newer avenues for risk reduction. Many organisms have been implicated, including herpesviruses, Chlamydia pneumoniae, Mycoplasma pneumoniae, periodontal pathogens, and ...

European Heart Journal, Natarajan, Pradeep, Cannon, Christopher P.

Date : 01/07/2011

In this section, we review the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet ...

European Heart Journal, Beckman, Joshua A., Paneni, Francesco, Cosentino, Francesco, Creager, Mark A.

Date : 14/08/2013 Item size : 738073 bytes

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study Abstract Aims The aim of this ...

European Heart Journal, Du, Xin, Ninomiya, Toshiharu, de Galan, Bastiaan, Abadir, Edward, Chalmers, John, Pillai, Avinesh, Woodward, Mark, Cooper, Mark, Harrap, Stephen, Hamet, Pavel, Poulter, Neil, ...

Date : 01/05/2009 Item size : 256602 bytes

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease Following multivariable adjustment for cardiovascular risk ...

European Heart Journal, Kastrup, Jens, Johansen, Julia S., Winkel, Per, Hansen, Jørgen Fischer, Hildebrandt, Per, Jensen, Gorm Boje, Jespersen, Christian M., Kjøller, Erik, Kolmos, Hans ...

Date : 01/05/2009 Item size : 264980 bytes

Abstract Aims It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. Methods and results In a ...

European Heart Journal, Sehestedt, Thomas, Jeppesen, Jørgen, Hansen, Tine W., Wachtell, Kristian, Ibsen, Hans, Torp-Petersen, Christian, Hildebrandt, Per, Olsen, Michael H.

Date : 01/04/2010 Item size : 254128 bytes